financetom
Business
financetom
/
Business
/
Grail Makes Cancer Early Detection Test Directly Available to US Physicians Via Quest Diagnostics Collaboration
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Grail Makes Cancer Early Detection Test Directly Available to US Physicians Via Quest Diagnostics Collaboration
Feb 12, 2025 7:27 AM

09:54 AM EST, 02/12/2025 (MT Newswires) -- Grail (GRAL) is making its Galleri multicancer early detection test directly available to physicians in the US through its collaboration with Quest Diagnostics ( DGX ) , the companies said Wednesday.

The companies said the test can now be ordered from Grail through Quest's connectivity system, helping streamline the process of ordering for physicians.

The integration of Grail's test into Quest's connectivity system will also increase availability by making the test accessible to patients at any Quest patient access point, the companies said.

Financial details of the collaboration weren't provided.

Price: 33.01, Change: -0.14, Percent Change: -0.42

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved